Tanezumab in Osteoarthritis Of The Hip
Recruiting in Palo Alto (17 mi)
+98 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 3
Waitlist Available
Sponsor: Pfizer
No Placebo Group
Pivotal Trial (Near Approval)
Prior Safety Data
Trial Summary
What is the purpose of this trial?
The purpose of this study is to test the efficacy and safety of 3 doses of tanezumab in osteoarthritis of the hip in patients
Research Team
PC
Pfizer CT.gov Call Center
Principal Investigator
Pfizer
Eligibility Criteria
Inclusion Criteria
Osteoarthritis of the hip according to ACR criteria with Kellgren-Lawrence x-ray grade of 2
Unwilling or unable to take non-opiate pain medications, for whom non-opiate pain medications have not provided adequate pain relief or are candidates for Hip injections, arthroplasty or replacement surgery
Pain level and function levels as required by the protocol at Screening and Baseline
See 3 more
Treatment Details
Interventions
- Placebo (Other)
- Tanezumab (Monoclonal Antibodies)
Participant Groups
4Treatment groups
Experimental Treatment
Group I: Tanezumab 5 mgExperimental Treatment1 Intervention
Tanezumab 5mg IV every 8 weeks
Group II: Tanezumab 2.5 mgExperimental Treatment1 Intervention
Tanezumab 2.5 mg IV every 8 weeks.
Group III: Tanezumab 10 mgExperimental Treatment1 Intervention
Tanezumab 10 mg IV every 8 weeks
Group IV: PlaceboExperimental Treatment1 Intervention
Placebo
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Javed Rheumatology Associates, Inc.Newark, DE
Innovative Research of West Florida, Inc.Clearwater, FL
Arthritis Associates of South FloridaDelray Beach, FL
The Arthritis CenterPalm Harbor, FL
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Pfizer
Lead Sponsor
Trials
4712
Patients Recruited
50,980,000+
Known For
Vaccine Innovations
Top Products
Viagra, Zoloft, Lipitor, Prevnar 13